Antiangiogenic strategies are commonly used to treat neoplasms such as VEGF neutralizing antibody (Avastin®), immunomodulatory drugs (IMiDs) [29] or the proteasome inhibitors, bortezomib and carfilzomib [30,31]. Here, VEGFA is linked to neoplasm.